Ga-66 labeled somatostatin analogue DOTA-DPhe 1 -Tyr 3 -octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors

This publication has 25 references indexed in Scilit:

• Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery
  Journal of Physiology-Paris, 2000
• Preclinical Comparison in AR4–2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Internal Radiotherapy*
  Endocrinology, 2000
• Peptide radiopharmaceuticals in nuclear medicine
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy
  Chemistry – A European Journal, 1999
• A Microplate Binding Assay for the Somatostatin Type-2 Receptor (SSTR2)
  Journal of Receptors and Signal Transduction, 1999
• An investigation of the physical characteristics of ⁶⁶Ga as an isotope for PET imaging and quantification
  Medical Physics, 1997
• Binding properties of somatostatin receptor subtypes
  Metabolism, 1996
• Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
  British Journal of Cancer, 1993
• Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23
  JNCI Journal of the National Cancer Institute, 1986
• Chemical processing of cyclotron- produced 67Ga
  The International Journal of Applied Radiation and Isotopes, 1971